Oxidative stress in the developing brain: Effects of postnatal glucocorticoid therapy and antioxidants in the rat

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Camm, Emily J ^a   Tijsseling, Deodata ^b   Richter, Hans G ^a   Adler, Alexandra ^a   Hansell, Jeremy A ^a   Derks, Jan B ^b   Cross, Christine M ^a   Giussani, Dino A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; DEXAMETHASONE SODIUM PHOSPHATE; GLUCOCORTICOID; HEAT SHOCK PROTEIN 70; SODIUM CHLORIDE;

ADVERSE OUTCOME; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN CELL; BRAIN DEVELOPMENT; BRAIN SIZE; BRAIN WEIGHT; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DENTATE GYRUS; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFECT; FEMALE; HIPPOCAMPAL CA1 REGION; MALE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PERINATAL DRUG EXPOSURE; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; BRAIN; GROWTH, DEVELOPMENT AND AGING; IMMUNOHISTOCHEMISTRY; METABOLISM; ORGAN SIZE; WESTERN BLOTTING; WISTAR RAT;

RATTUS;

ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; BODY WEIGHT; BRAIN; GLUCOCORTICOIDS; IMMUNOHISTOCHEMISTRY; MALE; ORGAN SIZE; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 79958831849     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021142     Document Type: Article

References (75)

1. Halliday HL, Ehrenkranz RA, Doyle LW, (2003) Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev pp. CD001146.
2. Papile LA, Tyson JE, Stoll BJ, Wright LL, Donovan EF, et al. (1998) A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. N Engl J Med 338: 1112-1118.
3. Halliday HL, Ehrenkranz RA, Doyle LW, (2003) Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev pp. CD001144.
4. Cummings JJ, D'Eugenio DB, Gross SJ, (1989) A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med 320: 1505-1510.
5. Halliday HL, Ehrenkranz RA, Doyle LW, (2003) Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev pp. CD001145.
6. Halliday HL, Ehrenkranz RA, Doyle LW, (2009) Early (<8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev pp. CD001146.
7. Halliday HL, Ehrenkranz RA, Doyle LW, (2009) Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev pp. CD001145.
8. Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, et al. (2000) Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 83: F177-181.
9. Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, et al. (2004) Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 350: 1304-1313.
10. Weichsel ME Jr, (1977) The therapeutic use of glucocorticoid hormones in the perinatal period: potential neurological hazards. Ann Neurol 2: 364-366.
11. Uno H, Eisele S, Sakai A, Shelton S, Baker E, et al. (1994) Neurotoxicity of glucocorticoids in the primate brain. Horm Behav 28: 336-348.
12. Huang WL, Beazley LD, Quinlivan JA, Evans SF, Newnham JP, et al. (1999) Effect of corticosteroids on brain growth in fetal sheep. Obstet Gynecol 94: 213-218.
13. Antonow-Schlorke I, Schwab M, Li C, Nathanielsz PW, (2003) Glucocorticoid exposure at the dose used clinically alters cytoskeletal proteins and presynaptic terminals in the fetal baboon brain. J Physiol 547: 117-123.
14. Kanagawa T, Tomimatsu T, Hayashi S, Shioji M, Fukuda H, et al. (2006) The effects of repeated corticosteroid administration on the neurogenesis in the neonatal rat. Am J Obstet Gynecol 194: 231-238.
15. Duksal F, Kilic I, Tufan AC, Akdogan I, (2009) Effects of different corticosteroids on the brain weight and hippocampal neuronal loss in rats. Brain Res 1250: 75-80.
16. Grier DG, Halliday HL, (2005) Management of bronchopulmonary dysplasia in infants: guidelines for corticosteroid use. Drugs 65: 15-29.
17. Pediatrics AAo, (2002) Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 109: 330-338.
18. Baden M, Bauer CR, Colle E, Klein G, Taeusch HW Jr, et al. (1972) A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome. Pediatrics 50: 526-534.
19. Rademaker KJ, de Vries LS, Uiterwaal CS, Groenendaal F, Grobbee DE, et al. (2008) Postnatal hydrocortisone treatment for chronic lung disease in the preterm newborn and long-term neurodevelopmental follow-up. Arch Dis Child Fetal Neonatal Ed 93: F58-63.
20. Schafer SC, Wallerath T, Closs EI, Schmidt C, Schwarz PM, et al. (2005) Dexamethasone suppresses eNOS and CAT-1 and induces oxidative stress in mouse resistance arterioles. Am J Physiol Heart Circ Physiol 288: H436-444.
21. Rajashree S, Puvanakrishnan R, (1998) Dexamethasone induced alterations in enzymatic and nonenzymatic antioxidant status in heart and kidney of rats. Mol Cell Biochem 181: 77-85.
22. Whitworth JA, Schyvens CG, Zhang Y, Andrews MC, Mangos GJ, et al. (2002) The nitric oxide system in glucocorticoid-induced hypertension. J Hypertens 20: 1035-1043.
23. Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, et al. (2003) Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 92: 81-87.
24. Zhang Y, Croft KD, Mori TA, Schyvens CG, McKenzie KU, et al. (2004) The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat. Am J Hypertens 17: 260-265.
25. McIntosh LJ, Sapolsky RM, (1996) Glucocorticoids increase the accumulation of reactive oxygen species and enhance adriamycin-induced toxicity in neuronal culture. Exp Neurol 141: 201-206.
26. McIntosh LJ, Hong KE, Sapolsky RM, (1998) Glucocorticoids may alter antioxidant enzyme capacity in the brain: baseline studies. Brain Res 791: 209-214.
27. Ahlbom E, Gogvadze V, Chen M, Celsi G, Ceccatelli S, (2000) Prenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stress-induced cell death. Proc Natl Acad Sci U S A 97: 14726-14730.
28. Behl C, Lezoualc'h F, Trapp T, Widmann M, Skutella T, et al. (1997) Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology 138: 101-106.
29. Evans PH, (1993) Free radicals in brain metabolism and pathology. Br Med Bull 49: 577-587.
30. Halliwell B, Gutteridge JMC, (1999) Free Radicals in Biology and Medicine Oxford Oxford University Press.
31. Frei B, England L, Ames BN, (1989) Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A 86: 6377-6381.
32. Burton GW, (1994) Vitamin E: molecular and biological function. Proc Nutr Soc 53: 251-262.
33. Coyle JT, Puttfarcken P, (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689-695.
34. Olanow CW, (1993) A radical hypothesis for neurodegeneration. Trends Neurosci 16: 439-444.
35. Behl C, (1997) Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease. Cell Tissue Res 290: 471-480.
36. de Vries WB, van der Leij FR, Bakker JM, Kamphuis PJ, van Oosterhout MF, et al. (2002) Alterations in adult rat heart after neonatal dexamethasone therapy. Pediatr Res 52: 900-906.
37. Bal MP, de Vries WB, van der Leij FR, van Oosterhout MF, Berger RM, et al. (2005) Neonatal glucocorticosteroid treatment causes systolic dysfunction and compensatory dilation in early life: studies in 4-week-old prepubertal rats. Pediatr Res 58: 46-52.
38. Carr A, Zhu C, Frei B, (2000) Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ Res 87: 349-354.
39. Jackson TS, Xu A, Vita JA, Keaney JF Jr, (1998) Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 83: 916-922.
40. Oncu M, Gultekin F, Karaoz E, Altuntas I, Delibas N, (2002) Nephrotoxicity in rats induced by chlorpryfos-ethyl and ameliorating effects of antioxidants. Hum Exp Toxicol 21: 223-230.
41. Wagner JP, Black IB, DiCicco-Bloom E, (1999) Stimulation of neonatal and adult brain neurogenesis by subcutaneous injection of basic fibroblast growth factor. J Neurosci 19: 6006-6016.
42. Gundersen HJ, Jensen EB, (1987) The efficiency of systematic sampling in stereology and its prediction. J Microsc 147: 229-263.
43. Eysel UT, Wolfhard U, (1984) The effects of partial retinal lesions on activity and size of cells in the dorsal lateral geniculate nucleus. J Comp Neurol 229: 301-309.
44. Mountjoy CQ, Roth M, Evans NJ, Evans HM, (1983) Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol Aging 4: 1-11.
45. Kiernan JA, Hudson AJ, (1991) Changes in sizes of cortical and lower motor neurons in amyotrophic lateral sclerosis. Brain 114 (Pt 2): 843-853.
46. Mitsui T, Umaki Y, Nagasawa M, Akaike M, Aki K, et al. (2002) Mitochondrial damage in patients with long-term corticosteroid therapy: development of oculoskeletal symptoms similar to mitochondrial disease. Acta Neuropathol 104: 260-266.
47. Wallerath T, Witte K, Schafer SC, Schwarz PM, Prellwitz W, et al. (1999) Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci U S A 96: 13357-13362.
48. Johns DG, Dorrance AM, Tramontini NL, Webb RC, (2001) Glucocorticoids inhibit tetrahydrobiopterin-dependent endothelial function. Exp Biol Med (Maywood) 226: 27-31.
49. Cai S, Alp NJ, McDonald D, Smith I, Kay J, et al. (2002) GTP cyclohydrolase I gene transfer augments intracellular tetrahydrobiopterin in human endothelial cells: effects on nitric oxide synthase activity, protein levels and dimerisation. Cardiovasc Res 55: 838-849.
50. Khassaf M, McArdle A, Esanu C, Vasilaki A, McArdle F, et al. (2003) Effect of vitamin C supplements on antioxidant defence and stress proteins in human lymphocytes and skeletal muscle. J Physiol 549: 645-652.
51. Sahin N, Tuzcu M, Orhan C, Onderci M, Eroksuz Y, et al. (2009) The effects of vitamin C and E supplementation on heat shock protein 70 response of ovary and brain in heat-stressed quail. Br Poult Sci 50: 259-265.
52. de la Monte SM, Neely TR, Cannon J, Wands JR, (2000) Oxidative stress and hypoxia-like injury cause Alzheimer-type molecular abnormalities in central nervous system neurons. Cell Mol Life Sci 57: 1471-1481.
53. Ansari MA, Roberts KN, Scheff SW, (2008) Oxidative stress and modification of synaptic proteins in hippocampus after traumatic brain injury. Free Radic Biol Med 45: 443-452.
54. Wilson JX, (2009) Mechanism of action of vitamin C in sepsis: ascorbate modulates redox signaling in endothelium. Biofactors 35: 5-13.
55. Heller R, Munscher-Paulig F, Grabner R, Till U, (1999) L-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells. J Biol Chem 274: 8254-8260.
56. Geetha A, Catherine J, Shyamala Devi CS, (1989) Effect of alpha-tocopherol on the microsomal lipid peroxidation induced by doxorubicin: influence of ascorbic acid. Indian J Physiol Pharmacol 33: 53-58.
57. Chen K, Keaney J, (2004) Reactive oxygen species-mediated signal transduction in the endothelium. Endothelium 11: 109-121.
58. Derks JB, Giussani DA, Jenkins SL, Wentworth RA, Visser GH, et al. (1997) A comparative study of cardiovascular, endocrine and behavioural effects of betamethasone and dexamethasone administration to fetal sheep. J Physiol 499 (Pt 1): 217-226.
59. Fletcher AJ, McGarrigle HH, Edwards CM, Fowden AL, Giussani DA, (2002) Effects of low dose dexamethasone treatment on basal cardiovascular and endocrine function in fetal sheep during late gestation. J Physiol 545: 649-660.
60. Lohle M, Muller T, Wicher C, Roedel M, Schubert H, et al. (2005) Betamethasone effects on fetal sheep cerebral blood flow are not dependent on maturation of cerebrovascular system and pituitary-adrenal axis. J Physiol 564: 575-588.
61. Daghini E, Chade AR, Krier JD, Versari D, Lerman A, et al. (2006) Acute inhibition of the endogenous xanthine oxidase improves renal hemodynamics in hypercholesterolemic pigs. Am J Physiol Regul Integr Comp Physiol 290: R609-615.
62. Versari D, Daghini E, Rodriguez-Porcel M, Sattler K, Galili O, et al. (2006) Chronic antioxidant supplementation impairs coronary endothelial function and myocardial perfusion in normal pigs. Hypertension 47: 475-481.
63. French NP, Hagan R, Evans SF, Godfrey M, Newnham JP, (1999) Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 180: 114-121.
64. Scheepens A, van de Waarenburg M, van den Hove D, Blanco CE, (2003) A single course of prenatal betamethasone in the rat alters postnatal brain cell proliferation but not apoptosis. J Physiol 552: 163-175.
65. Thorp JA, Jones PG, Peabody JL, Knox E, Clark RH, (2002) Effect of antenatal and postnatal corticosteroid therapy on weight gain and head circumference growth in the nursery. Obstet Gynecol 99: 109-115.
66. Flagel SB, Vazquez DM, Watson SJ Jr, Neal CR Jr, (2002) Effects of tapering neonatal dexamethasone on rat growth, neurodevelopment, and stress response. Am J Physiol Regul Integr Comp Physiol 282: R55-63.
67. He J, Varma A, Weissfeld LA, Devaskar SU, (2004) Postnatal glucocorticoid exposure alters the adult phenotype. Am J Physiol Regul Integr Comp Physiol 287: R198-208.
68. Neal CR Jr, Weidemann G, Kabbaj M, Vazquez DM, (2004) Effect of neonatal dexamethasone exposure on growth and neurological development in the adult rat. Am J Physiol Regul Integr Comp Physiol 287: R375-385.
69. Munck A, (1971) Glucocorticoid inhibition of glucose uptake by peripheral tissues: old and new evidence, molecular mechanisms, and physiological significance. Perspect Biol Med 14: 265-269.
70. Weiler HA, Wang Z, Atkinson SA, (1997) Whole body lean mass is altered by dexamethasone treatment through reductions in protein and energy utilization in piglets. Biol Neonate 71: 53-59.
71. Fowden AL, Forhead AJ, (2004) Endocrine mechanisms of intrauterine programming. Reproduction 127: 515-526.
72. Sicard RE, Werner JC, (1992) Dexamethasone induces a transient relative cardiomegaly in neonatal rats. Pediatr Res 31: 359-363.
73. Thibeault DW, Heimes B, Rezaiekhaligh M, Mabry S, (1993) Chronic modifications of lung and heart development in glucocorticoid-treated newborn rats exposed to hyperoxia or room air. Pediatr Pulmonol 16: 81-88.
74. Adler A, Camm EJ, Hansell JA, Richter HG, Giussani DA, (2010) Investigation of the Use of Antioxidants to Diminish the Adverse Effects of Postnatal Glucocorticoid Treatment on Mortality and Cardiac Development. Neonatology 98: 73-83.
75. Daniels VG, Hardy RN, Malinowska KW, Nathanielsz PW, (1973) The influence of exogenous steroids on macromolecule uptake by the small intestine of the new-born rat. J Physiol 229: 681-695.